Rifapex, a New Antituberculosis Agent
Сlinісо-roentgenologlc and bacteriologic efficacy and safety of rifapex (rifapentin) were investigated in the complex therapy of 90 patients with newly recorded drug-susceptible tuberculosis. Pifapex was shown to be effective in the treatment of the patients during the acute phase of the disease, du...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849692734201266176 |
|---|---|
| author | G. B. Sokolova V. A. Krasnov T. A. Reikhrud A. A. Tsybanev |
| author_facet | G. B. Sokolova V. A. Krasnov T. A. Reikhrud A. A. Tsybanev |
| author_sort | G. B. Sokolova |
| collection | DOAJ |
| description | Сlinісо-roentgenologlc and bacteriologic efficacy and safety of rifapex (rifapentin) were investigated in the complex therapy of 90 patients with newly recorded drug-susceptible tuberculosis. Pifapex was shown to be effective in the treatment of the patients during the acute phase of the disease, during the treatment completeness and during the short preoperative period. |
| format | Article |
| id | doaj-art-873daad2949c4a0888e84bdba2d2cb11 |
| institution | DOAJ |
| issn | 0235-2990 |
| language | Russian |
| publishDate | 2020-05-01 |
| publisher | LLC "Publishing House OKI" |
| record_format | Article |
| series | Антибиотики и Химиотерапия |
| spelling | doaj-art-873daad2949c4a0888e84bdba2d2cb112025-08-20T03:20:37ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01541-23841202Rifapex, a New Antituberculosis AgentG. B. Sokolova0V. A. Krasnov1T. A. Reikhrud2A. A. Tsybanev3I.M. Sechenov Moscow Medical Academy, Moscow; Novosibirsk Research Institute of TuberculosisI.M. Sechenov Moscow Medical Academy, Moscow; Novosibirsk Research Institute of TuberculosisI.M. Sechenov Moscow Medical Academy, Moscow; Novosibirsk Research Institute of TuberculosisI.M. Sechenov Moscow Medical Academy, Moscow; Novosibirsk Research Institute of TuberculosisСlinісо-roentgenologlc and bacteriologic efficacy and safety of rifapex (rifapentin) were investigated in the complex therapy of 90 patients with newly recorded drug-susceptible tuberculosis. Pifapex was shown to be effective in the treatment of the patients during the acute phase of the disease, during the treatment completeness and during the short preoperative period.https://www.antibiotics-chemotherapy.ru/jour/article/view/203drug susceptible tuberculosiscomplex therapyrifapentin |
| spellingShingle | G. B. Sokolova V. A. Krasnov T. A. Reikhrud A. A. Tsybanev Rifapex, a New Antituberculosis Agent Антибиотики и Химиотерапия drug susceptible tuberculosis complex therapy rifapentin |
| title | Rifapex, a New Antituberculosis Agent |
| title_full | Rifapex, a New Antituberculosis Agent |
| title_fullStr | Rifapex, a New Antituberculosis Agent |
| title_full_unstemmed | Rifapex, a New Antituberculosis Agent |
| title_short | Rifapex, a New Antituberculosis Agent |
| title_sort | rifapex a new antituberculosis agent |
| topic | drug susceptible tuberculosis complex therapy rifapentin |
| url | https://www.antibiotics-chemotherapy.ru/jour/article/view/203 |
| work_keys_str_mv | AT gbsokolova rifapexanewantituberculosisagent AT vakrasnov rifapexanewantituberculosisagent AT tareikhrud rifapexanewantituberculosisagent AT aatsybanev rifapexanewantituberculosisagent |